Kion Group Gmbh

BioGaia AB (STO:BIOGB) BioGaia's subsidiary CapAble has licenced the rights to use LifeTop(TM) Cap with Reuteri to the Mexican bottled water company Aqua Scandik.

BioGaia AB (STO:BIOGB) CapAble has signed a licence agreement with the American company Mass Probiotics. The agreement gives Mass Probiotics rights to use CapAble's unique packaging solution LifeTop(TM) Cap on its beverages in the USA and Canada.

BioGaia AB (STO:BIOGB) BioGaia has started delivery of products according to the development and sales agreement that was signed 2003 with one of China's largest dairies. The delivery concerns BioGaia's patented straw, LifeTop Straw.

BioGaia AB (STO:BIOGB) BioGaia has extended its collaboration with the Swiss biopharmaceutical company Ferring Pharmaceuticals giving Ferring exclusive rights to sell BioGaia's Probiotic Drops in Ireland and exclusive rights to sell BioGaia's Probiotic Drops and Tablets in Bahrain, Yemen, Qatar, Oman, Kuwait and United Arab Emirates.

BioGaia AB (STO:BIOGB) BioGaia has signed an agreement with Delta Medical Promotions A.G., Switzerland which gives the company exclusive rights to sell BioGaia's Probiotic Drops in Kazakhstan and BioGaia's Probiotic tablets in Ukraine and Kazakhstan.

BioGaia AB (STO:BIOGB) A new study confirms that chewing gum from BioGaia containing Lactobacillus reuteri Prodentis reduces gingivitis (inflamed gums). The study also shows that the Lactobacillus reuteri Prodentis can interact directly with the human immune system to reduce inflammation.

BioGaia AB (STO:BIOGB) Press Release, 23 October, 2008 (11 pages) BioGaia AB Interim Report 1 January - 30 September 2008 (Figures in brackets refer to the same period of last year) * Net sales amounted to SEK 106.0 million (74.6), an increase of SEK 31.4 million (42%) compared to the same period of last year. * Operating profit was SEK 18.4 million (3.3), an improvement of SEK 15.1 million compared to the same period of last year. * Profit before tax was SEK 20.1 million (4.4), an improvement of SEK 15.7 million compared to the same period of last year. * Profit after tax was SEK 31.1 million (4.4), an improvement of SEK 26.7 million over the same period of last year. Profit for the period includes a tax benefit of SEK 11 million pertaining to a change in the deferred tax asset. * Earnings per share were SEK 1.81 (0.25). * The period's cash flow from operating activities before change in working capital was SEK 23.3 million (8.5). Total cash flow for the period was SEK ...

BioGaia AB (STO:BIOGB) BioGaia has decided to intensify its sales commitment to its patented LifeTop Cap technology in a newly formed subsidiary CapAble AB.

BioGaia AB (STO:BIOGB) Nestlé Nutrition's HealthCare Nutrition business unit (HCN) is now launching BOOST® Kid Essentials with BioGaia's patented probiotic straw in the US.

BioGaia AB has signed an exclusive agreement with Norwegian-based Kavli Holding AS that gives Kavli the right to use BioGaia's patented probiotic Lactobacillus Reuteri Protectis in dairy products in Norway. Kavli's subsidiary Q-Meirierne AS is now launching the BioQ yoghurt drink on the Norwegian market.